Dietary Sodium and Cardiovascular Disease
Although an essential nutrient, higher sodium intake is associated with increasing blood pressure (BP), forming the basis for current population-wide sodium restriction guidelines. While short-term clinical trials have achieved low intake (<2.0 g/day), this has not been reproduced in long-term trials (>6 months). Guidelines assume that low sodium intake will reduce BP and reduce cardiovascular disease (CVD), compared to moderate intake. However, current observational evidence suggests a J-shaped association between sodium intake and CVD; the lowest risks observed with 3–5 g/day but higher risk with <3 g/day. Importantly, these observational data also confirm the association between higher intake (>5 g/day) and increased risk of CVD. Although lower intake may reduce BP, this may be offset by marked increases in neurohormones and other adverse effects which may paradoxically be adverse. Large randomised clinical trials with sufficient follow-up are required to provide robust data on the long-term effects of sodium reduction on CVD incidence. Until such trials are completed, current evidence suggests that moderate sodium intake for the general population (3–5 g/day) is likely the optimum range for CVD prevention.
KeywordsSodium Salt intake Cardiovascular disease Hypertension Guidelines
No funding was received for the current article. Authors received funding from the Heart and Stroke Foundation of Ontario for PURE Salt Study of association of sodium intake and cardiovascular events and mortality.
Compliance with Ethics Guidelines
Conflict of Interest
Andrew Smyth, Martin O’Donnell, Andrew Mente and Salim Yusuf declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 2.Powles J, Fahimi S, Micha R, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3:e003733.Google Scholar
- 3.•Mente A, O’Donnell MJ, Rangarajan S, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371:601–11. This prospective cohort study (n = 102,216 from 18 countries), primarily of people without established cardiovascular disease, showed a nonlinear association between sodium intake (measured using fasting morning urine samples) and blood pressure, with stronger relationships seen in older persons, those consuming high-sodium diets and those with hypertension. PubMedCrossRefGoogle Scholar
- 14.Anderson CA, Appel LJ, Okuda N, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc. 2010;110:736–45.Google Scholar
- 16.•Rakova N, Juttner K, Dahlmann A, et al. Long-term space flight simulation reveals infradian rhythmicity in human Na(+) balance. Cell Metab. 2013;17:125–31. This study of men completing space flight simulations that consumed fixed salt intake showed rhythmic sodium excretion and retention patterns occur independent of blood pressure, body water and salt intake. PubMedCrossRefGoogle Scholar
- 17.Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol. 1993;20:7–14.Google Scholar
- 20.Cogswell ME, Wang CY, Chen TC, et al. Validity of predictive equations for 24-h urinary sodium excretion in adults aged 18–39 years. Am J Clin Nutr. 2013;98:1502–13.Google Scholar
- 24.Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev 2011:CD004022.Google Scholar
- 29.•Whelton PK, Appel LJ, Sacco RL, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126:2880–9. This review article is a key paper as it represents the opinion of the American Heart Association and includes their justification for the AHA guideline recommendations to reduce dietary sodium intake to <1500 mg/day.Google Scholar
- 32.The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The trials of hypertension prevention, phase II. Arch Intern Med. 1997;157:657–67.CrossRefGoogle Scholar
- 35.•O’Donnell MJ, Yusuf S, Mente A, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306:2229–38. This prospective cohort study (a post-hoc analysis of the ONTARGET and TRANSCEND trials, n = 28,880) showed a nonlinear relationship between estimated sodium intake and cardiovascular events, with the lowest risk observed with intake of 4–5.99 g/day. Google Scholar
- 36.•O’Donnell M, Mente A, Rangarajan S, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371:612–23. This prospective cohort study (n = 101,945 from 17 countries), primarily of people without established cardiovascular disease, showed a nonlinear relationship between estimated sodium intake (measured using fasting morning urine samples) and death and cardiovascular disease, with the lowest risk observed with intake of 3–6 g/day. Google Scholar
- 37.•Joosten MM, Gansevoort RT, Mukamal KJ, et al. Sodium excretion and risk of developing coronary heart disease. Circulation. 2014;129:1121–8. This prospective cohort study (n = 7,543) of people without cardiovascular or kidney disease showed no overall association between sodium intake (measured using two 24-h urine collections) and risk of coronary heart disease, although higher intake was associated with an increased risk of coronary heart disease in those with hypertension or those with increased plasma N-terminal pro-B-type natriuretic peptide. PubMedCrossRefGoogle Scholar
- 38.•Thomas MC, Moran J, Forsblom C, et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011;34:861–6. This prospective cohort study (n = 2,807) of people with type 1 diabetes mellitus but without end-stage renal disease showed that sodium intake (measured using 24-h urine collection) was nonlinearly associated with all-cause mortality, as those with the highest and lowest sodium intakes were associated with reduced survival. PubMedCentralPubMedCrossRefGoogle Scholar
- 40.•Saulnier PJ, Gand E, Hadjadj S, Group SS. Sodium and cardiovascular disease. N Engl J Med. 2014;371:2135–6. This prospective cohort study (n = 1,439, France) of patients with type 2 diabetes showed a nonlinear relationship between sodium excretion and cardiovascular mortality, with the lowest risk observed with intake 5–6 g/day. Google Scholar
- 41.•Pfister R, Michels G, Sharp SJ, et al. Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC-Norfolk study. Eur J Heart Fail. 2014;16:394–402. This prospective cohort study (n = 19,857, UK) of patients aged 40–79 attending general practices showed a U-shaped association between 24-h urinary sodium excretion and heart failure, with the lowest risk observed with intake of 3.5 g/day (150 mmol/day). Google Scholar
- 42.•Kalogeropoulos AP, Georgiopoulou VV, Murphy RA, et al. Dietary sodium content, mortality, and risk for cardiovascular events in older adults: the health, aging, and body composition (health ABC) study. JAMA Intern Med. 2015;175:410–9. This prospective cohort study (n = 2,642, USA) of adults aged 71–80 years showed that sodium intake was not associated with mortality, incident cardiovascular disease or heart failure and a nonsignificant tendency towards a J-shaped association. Google Scholar